- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03828916
NuShield in Surgical Peroneal Tendon Repair
January 13, 2020 updated by: NuTech Medical, Inc
Single Arm Clinical Evaluation of the Safety and Efficacy of the NuShield® Allograft for Peroneal Tendon Repair
The purpose of this study is to evaluate the use of NuShield in subjects requiring surgical tendon repair.
Study Overview
Detailed Description
The objective of this clinical trial is to evaluate both the safety and efficacy of using the NuShield® allograft in addition to standard of care surgical procedures in subjects requiring surgical repair of the peroneal tendon. The effects of this treatment will be assessed using:
Questionnaires
- Visual Analog Scale Foot and Ankle (VAS FA)
- FAAM Sport
- PROMIS Global Health SF
- Tegner Activity Scale
- Foot and Ankle Outcomes Instrument (Q1, Q2)
- Swelling assessments
- Ultrasound imaging for tendon thickness, gliding and adhesion formation
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Katie Mowry
- Phone Number: 205-800-8301
- Email: kmowry@organo.com
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35205
- Recruiting
- Central Research Associates, Inc.
-
Contact:
- Shannon Helton, RN
- Phone Number: 205-327-1077
- Email: shannon@centraltrials.com
-
Principal Investigator:
- Norman Waldrop, M.D.
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- Recruiting
- University of Colorado Health Orthopedics Clinic - Anschutz Medical Campus
-
Contact:
- Phone Number: 720-848-1900
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 58 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Ages 18 to 60 inclusive
- If female, actively practicing a medically relevant method of contraception, abstinent, surgically sterile, or post-menopausal (defined as no menses for at least 12 months)
Have a diagnosis of one of the following in relation to the peroneal tendon:
- Tendonitis with MRI confirmation
- Synovial inflammation
- Tear
- Diagnosis resulting from acute injury to the tendon
Exclusion Criteria:
- BMI equal to or greater than 35
- Prior injury to the peroneal tendon
- Collagen disorders
- Inflammatory arteriopathies
- Immune compromised
- Diabetic
- Less than 6 months between injury and proposed surgery date
- Steroid injection within the past 6 weeks localized to the treatment area
- Pregnant within the past six (6) months, breast feeding and/or desire to become pregnant during the course of the study, as verified by urine pregnancy test within one week prior to treatment
- History of more than two (2) weeks treatment with immuno-suppressants, including systemic corticosteroids or cytotoxic chemotherapy within one month prior to initial screening, or have received such medications during the screening period, or are anticipated to require such medications during the course of the study
- Taking any investigational drug(s) or therapeutic device(s) within 30 days preceding screening
- History of radiation therapy of the affected foot
- Known history of having Acquired Immunodeficiency Syndrome (AIDS) or HIV
- Currently involved in medical litigation, including Worker's Compensation claims of any type
- Unable to understand the objectives of the trial
- Presence of any condition(s) which, in the opinion of the investigator, would compromise the subject's ability to complete this study
- Having a known history of poor adherence with medical treatment
- Express an unwillingness to receive human allograft tissue
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: NuShield
|
SOC surgery with the addition of NuShield
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
VAS Foot and Ankle Pain
Time Frame: 6 Months
|
Visual Analogue Scale (VAS) foot and ankle pain.
Change in pain intensity scores from baseline.
VAS is measured in mm (scale 0-100); with 0 indicating worse outcomes and 100 indicating better outcome
|
6 Months
|
FAAM Sports Subscale
Time Frame: 6 Months
|
Foot and Ankle Ability Measure (FAAM) Sports Subscale.
Changes in FAAM Sport scores from baseline (scale 0-4); with 0 indicating better outcomes and 4 indicating worse outcomes
|
6 Months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adverse Events
Time Frame: up to 1 year
|
Evaluations of safety will include serious adverse events or observed and/or volunteered adverse events.
|
up to 1 year
|
Swelling assessment by investigator
Time Frame: 6 and 12 months
|
Circumferential measurement of the limbs.
Change in swelling measured in cm
|
6 and 12 months
|
PROMIS Global Health Subscale
Time Frame: 6 and 12 months
|
PROMIS® (Patient-Reported Outcomes Measurement Information System) Global Health Subscale.
Changes from baseline (scale 1-5); with 5 indicating better outcomes and 1 indicating worse outcomes
|
6 and 12 months
|
Tegner Activity Scale
Time Frame: 6 and 12 months
|
Tegner Activity Scale (scale 0-10).
Changes from baseline; with 0 indicating worse outcomes and 10 indicating better outcomes
|
6 and 12 months
|
Foot and Ankle Outcome Instrument, Questions 1 and 2 (subscale)
Time Frame: 6 and 12 months
|
Patient reported outcome (PRO) measurement of stiffness and swelling (1-5); with 1 indicating better outcomes and 5 indicating worse outcomes
|
6 and 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 30, 2019
Primary Completion (Anticipated)
June 1, 2021
Study Completion (Anticipated)
June 1, 2021
Study Registration Dates
First Submitted
July 20, 2018
First Submitted That Met QC Criteria
January 31, 2019
First Posted (Actual)
February 4, 2019
Study Record Updates
Last Update Posted (Actual)
January 14, 2020
Last Update Submitted That Met QC Criteria
January 13, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RD2018-01-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tendon Injuries
-
Zimmer BiometEmbody Inc.Enrolling by invitation
-
University of FloridaRecruitingProspective Randomized Blinded Trial of VersaWrap Tendon Protector for Zone 2 Flexor Tendon InjuriesFlexor TendonUnited States
-
Aristotle University Of ThessalonikiGeneral Hospital of Naoussa; Private Orthopedics Practice P. SymeonidisEnrolling by invitationAchilles Tendon Rupture | Achilles Tendon Injury | Achilles Tendon SurgeryGreece
-
University of ZurichCompleted
-
University of HaifaZinman College of Physical Education and Sports SciencesNot yet recruiting
-
University of Western Ontario, CanadaNot yet recruitingTendon Injury - Hand
-
Rambam Health Care CampusCompletedHand Tendon InjuryIsrael
-
Mina Micheal Anwer FahmyUnknown
-
Tampere UniversityTampere University Hospital; Central Finland Hospital DistrictTerminatedFlexor Tendon InjuryFinland
Clinical Trials on NuShield
-
OrganogenesisRecruitingDiabetic Foot UlcerUnited States
-
NuTech Medical, IncOrganogenesisCompletedFoot Ulcer, DiabeticUnited States